Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drug

Por Okada, Masashi, Takeda, Hiroyuki, Sakaki, Hirotsugu, Kuramoto, Kenta, Suzuki, Shuhei, Sanomachi, Tomomi, Togashi, Keita, Seino, Shizuka, Kitanaka, Chifumi
Publicado no Oncotarget (2017)